Table 3.

Correlation between GA and clinicopathological characteristics in 89 young patients with LUAD

	ALL	GA	P	EGFR	P	ERBB2	P	ALK	P	TP53	P
Gender			0.280		0.846		0.922		0.620		1.000
Males	25	19(76.0%)		5(20.0%)		6(24.0%)		5(20.0%)		2(8.0%)
Females	64	41(64.1%)		14(21.9%)		16(25.0%)		10(15.6%)		6(9.4%)
Differentiation			0.000		0.001		0.000		0.000		0.001
Well	54	27(50.0%)		5(9.3%)		18(33.3%)		1(1.9%)		2(3.7%)
Moderate	13	12(92.3%)		7(53.8%)		4(30.8%)		1(7.7%)		1(7.7%)
Poor	22	21(95.5%)		7(31.8%)		0		13(59.1%)		5(22.7%)
Stage			0.002		0.214		0.103		0.000		0.129
I-III	74	45(60.8%)		14(18.9%)		21(28.4%)		7(9.5%)		5(6.8%)
IV	15	15(100%)		5(33.3%)		1(6.7%)		8(53.3%)		3(20.0%)
Smoking status			0.261		1.000		0.684		0.173		0.590
Smokers	9	8(88.9%)		2(22.2%)		3(33.3%)		3(33.3%)		1(11.1%)
Never	80	52(65.0%)		17(21.3%)		19(23.8%)		12(15.0%)		7(8.8%)